To validate our hypothesis, we examined STING/IFN‐γ expression in cultured Vδ2 γδ T cells from patients with lung cancer and observed significantly lower STING expression in lung cancer patients than in healthy donors (Figure 4A,B). This evidence concerns the gene STING1 and lung cancer.